Fingerprint
Dive into the research topics of 'Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade®) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically